(Information sent by the signatory company)
Amsterdam, February 27, 2024 – Royal Philips, a leading health technology company, today announced significant improvements to its image-guided therapy system, Azurion, with the introduction of the brand’s new biplane angiograph. This new system incorporates greater flexibility in patient positioning and image capture, and is designed to make neurovascular procedures more efficient and help healthcare professionals make better decisions faster, treat more patients and obtain better results. better clinical results.
The interventions that can be carried out with the new Azurion biplane range from the accelerated diagnosis and treatment of stroke cases, where every minute counts when it comes to preserving the patient’s quality of life, to the precise planning and execution of neurovascular procedures. complexes such as the repair of brain aneurysms or congenital defects.
By enabling neurointerventionalists to treat more patients more effectively and with potentially better outcomes, the new Azurion biplane system improves both the healthcare provider and patient experience and helps reduce the cost of care.
“We have designed the latest Azurion biplane in collaboration with interventional experts to meet their needs for improved patient care, optimized performance in the angiography suite and efficient return on investment,” said Bert van Meurs, director of the Philips Image Guided Therapy business unit. “By working together, I am confident we can reduce the impact of stroke and help patients return to a healthy life,” he added.
The Philips biplane guided therapy system is designed to facilitate and optimize procedural workflows where a combination of 2D and 3D images is needed for confident diagnosis and precise treatment. Used in conjunction with the company’s latest Neuro Suite software and services, it provides neurointerventionalists with a fully integrated solution that combines Philips ClarityIQ low-dose imaging with a range of dedicated neurology tools* and value-added services that They offer unprecedented levels of efficiency, flexibility and control.
New capabilities of the Azurion biplane neurose system include enhanced C-arm rotation, angulation and parking capabilities that enable rapid transition between 2D and 3D imaging, comprehensive tabletop control that eliminates the need to leave the sterile field, automatic beam rotation for correctly oriented images at every angulation and rotation, and a new head immobilizer to improve stroke care.
Accelerate stroke treatment
One in four adults over 25 years of age will suffer a stroke at some point in their lives [1]. Globally, the direct and indirect cost has been estimated at about $891 billion per year [2]. The key to reducing the personal, social and economic impact of stroke is to follow the axiom “time is brain.” The sooner the stroke is treated, the better the potential outcome.
In the case of ischemic stroke, which represents 87% of all strokes [3], the advantages of administering intra-arterial treatment (IAT), procedures based on the introduction of a catheter to mechanically interrupt or remove blood clots, are widely accepted. (mechanical thrombectomy) and/or inject anticoagulant agents, within 6 hours of the onset of symptoms [4]. As mechanical thrombectomy has become the standard for the treatment of ischemic stroke due to large vessel occlusion, demand has rapidly increased for high-use angiographs that allow interventionalists to operate quickly and effectively.
In addition to the efficiency-enhancing features of its Azurion platform, Philips is maximizing the uptime of its angiography suite solutions by using complex artificial intelligence (AI) and machine learning algorithms to monitor system performance at through the new Philips ServiceHub remote connection services. These services proactively communicate, monitor and respond to potential service issues, for example by predicting likely component failures at least 7 days in advance so planned preventive measures can be taken.
Committed to innovation
In addition to introducing its new biplane image-guided treatment system, Philips is also developing a potentially faster route, Direct-to-Angio-Suite (DTAS), in which stroke patients are diagnosed and treated directly in the patient’s room. angiography using cone beam CT imaging. Philips has sponsored the WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) clinical trial [5]. The trial is being conducted primarily with the Philips Azurion image-guided therapy system.
With its comprehensive portfolio of stroke treatment products, Philips is uniting caregivers, wherever they are, at every vital step of the stroke treatment process. The result is intelligent solutions designed to support connected care. Visit Philips in
Care Means the World
Philips innovations are underpinned by the company’s commitment to driving sustainable healthcare, developing solutions that help care for patients and the planet with the same care and dedication. Those attending the event
References:
* SmartCT Soft Tissue helical, Aneurysm Flow, SmartCT Dual Phase Cerebral[1] World Stroke Organization (WSO): Global Stroke Fact Sheet 2022 ( https://www.world-stroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf)
[2] Owolabi MO, Thrift AG, Mahal A, et al.; Stroke Experts Collaboration Group. Primary stroke prevention worldwide: translating evidence into action. Lancet Public Health. 2022 Jan;7(1):e74-e85. doi: 10.1016/S2468-2667(21)00230-9. Epub 2021 Oct 29. Erratum in: Lancet Public Health. 2022 Jan;7(1):e14. PMID: 34756176; PMCID: PMC8727355. https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00230-9/fulltext
[3] Virani S.S., Alonso A., Benjamin E.J., et al. Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000757?rfr_dat=cr_pub 0pubmed
[4] NHS England UK : https://www.england.nhs.uk/wp-content/uploads/2019/05/Mechanical-thrombectomy-for-acute-ischaemic-stroke-ERRATA-29-05-19.pdf
[5] WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment). Sponsored by Philips. https://www.wetrust-study.com/
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHI) is a leading health technology company, focused on improving people’s health and well-being, and facilitating better results in the health cycle, from habits healthy and prevention, to diagnosis, treatment and home care. Philips leverages its advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as consumer health and home care. Philips has recorded sales of €17.8 billion in 2022 and employs approximately 71,500 employees, with business operations and services in more than 100 countries. All news about Philips can be found in our News Center
For more information:
César García Requena
Brand
Philips Ibérica
Tel : 670 264 471
Email: cesar.garcia.requena@philips.com
Ruben Marcos / Daniel Calvo
Europa Press Communication
Tel: 91 359 26 00
E-mail: rubenmarcos@europapress.es / danielcalvo@europapress.es
